Verve Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Orakl Oncology, a spin-off from Gustave Roussy, builds an AI-and-biology platform that grows patient-derived tumor organoids and enriches them with genomic, transcriptomic, phenotypic, and clinical data to predict drug response and clinical trial outcomes.
AI & Machine LearningBiotechHealthtech
Diane-Laure Pagès(Founder)in
Co-investorsHCVCSistaBpifranceSingularSpeedinvest
Puraffinity develops adsorbent media engineered for the removal of PFAS from water, offered as bulk media, pre-filled vessels, or full treatment services.
CleantechClimate TechNew MaterialsLondon, GB
Co-investorsExtantia CapitalHG VenturesKindred CapitalOctopus VenturesUniversal Materials IncubatorAcequia Capital (AceCap)
Wingtra builds aerial survey drones (such as the WingtraRAY) along with a connected app for planning, capturing, processing, and exporting mapping data into CAD and GIS workflows.
Deep TechHardwareRoboticsZürich, CH
Elias Kleimann(Founder)Maximilian Boosfeld(Founder)in
Co-investorsBrick Mortar VenturesACE & CompanyEquityPitcher VenturesEuropean Innovation Council Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.